Survival motor neuron protein-independent amelioration of spinal muscular atrophy by pharmacological inhibition of c-Jun-NH2 terminal kinase

Brain Communications · Published 2026-01-01 · DOI 10.1093/braincomms/fcag111

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1093/braincomms/fcag111

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Intracellular fluid accumulation underlies brain volume increases in early Alzheimer’s disease · Brain Communications · 2026 · Same journal
• Incomplete T cell tolerance and epitope-specific responses to the NR1 subunit in NMDA receptor antibody-associated encephalitis · Brain Communications · 2026 · Same journal
• Brain-injury and Alzheimer’s disease biomarkers are elevated in patients with suspected infection and physiological derangement: importance for context-specific interpretation of Alzheimer’s biomarkers · Brain Communications · 2026 · Same journal
• Individualized phenotyping of functional amyotrophic lateral sclerosis pathology in sensorimotor cortex · Brain Communications · 2026 · Same journal
• Soluble high-molecular-weight amyloid-β species derived from amyloid-β-laden brains induce cerebral β-amyloidosis · Brain Communications · 2026 · Same journal
• Classifying irritable bowel syndrome using spatio-temporal graph convolution networks on brain functional MRI data · Brain Communications · 2026 · Same journal
• Neurological manifestations and genotype–phenotype correlations in NDUFAF6 -associated mitochondrial disease · Brain Communications · 2026 · Same journal
• Long-term effects of preterm birth on cortical folding trajectories in early childhood · Brain Communications · 2026 · Same journal
• Dual mechanism of anti-seizure medications in controlling seizure activity · Brain Communications · 2026 · Same journal
• Unbiased data-driven analysis of five amyloid-beta peptides for biomarker investigations in familial Alzheimer’s disease · Brain Communications · 2026 · Same journal